Dengvaxia: What Healthcare Professionals Need to Know
PROGRAM DESCRIPTION: This learning activity will provide an overview on eligibility criteria for the dengue vaccine, pre-vaccination screening recommendations, and vaccine storage, handling, and administration.
OBJECTIVES:
At the end of this course, participants will be able to:
- Describe the epidemiology and clinical manifestations of dengue.
- Describe dengue risk reduction and prevention measures.
- Identify areas where dengue is endemic.
- Describe indications for using the dengue vaccine in the United States.
- Explain required pre-vaccination screening and eligibility criteria for Dengvaxia.
- Identify Dengvaxia vaccine storage, handling, and administration.
- Describe the importance of interprofessional collaboration in public health settings when addressing dengue prevention.
FACULTY/ CREDENTIALS:
LCDR Joshua M. Wong, MD, EIS Officer, CDC Dengue Branch
ORIGINATION DATE: March 17, 2022
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser
MATERIALS: Computer, Internet
TARGET AUDIENCE: Physicians, Registered Nurses, Administrators, Advanced Practice Nurses, Certified Health Educators, DO, Laboratorians, Licensed Practical/Vocational Nurses
PREREQUISITES: Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization, and vaccine-preventable diseases.
FORMAT: This activity is Web on Demand.
CONTACT INFORMATION: CDC, Dengue Branch, (787) 706-2399 dengue@cdc.gov
ACCREDITATION STATEMENTS
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 0.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0.5. Continuing Competency credits available are 0.5. CDC provider number 98614.
DISCLOSURE:
CDC, our planners, content experts and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
In order to receive continuing education (CE) for WD4550 – Dengvaxia: What Healthcare Professionals Need to Know, please visit TCEO and follow these 9 Simple Steps before March 17, 2024.
Complete the activity
Complete the Evaluation at www.cdc.gov/GetCE
Pass the posttest at 80% at www.cdc.gov/GetCE
FEES: No fees are charged for CDC’s CE activities.